Feature|Videos|September 30, 2024
Challenges in Analyzing Antisense Oligonucleotides (ASOs)
Author(s)LCGC Editors
The main focus of this Peer Exchange is on the state of the art for antisense oligonucleotides (ASOs) in particular. The panel shares their perspectives on the most pressing analytical challenges the industry currently faces regarding these oligonucleotides.
Episodes in this series
The panel discusses current challenges in oligonucleotide analysis, particularly in the case of ASOs. Claus Rentel of Ionis Pharmaceuticals mentions that often, working with ASOs, the impurity profile is a main concern. Arnaud Delobel adds that mass spectrometry (MS) is required to analyze oligonucleotides fully. From an academic perspective, Mark Dickman suggests that the diversity of new chemical modalities and modifications present additional complexities.
Related Content
Trending on LCGC International
1
HILIC vs Reversed-Phase LC for Central Carbon Metabolism Profiling
2
LC-MS/MS Links Vitamin D Levels to Sleep Timing
3
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
4
Highlights from the HPLC2026 Conference through the Lens of LC Troubleshooting
5